Last reviewed · How we verify

NCT05323292

Vitamin A Status in Patients With Vocal Fold Leukoplakia

ENROLLING BY INVITATION Last updated 17 December 2025
What this trial tests

trial in Vitamin A in 90 participants. Enrolling by invitation.

Timeline
29 June 2022
Primary endpoint
30 June 2026
31 December 2026

Quick facts

Lead sponsorUniversity of Wisconsin, Madison
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment90
Start date29 June 2022
Primary completion30 June 2026
Estimated completion31 December 2026
Sites1 location across United States

Conditions studied

Sponsor

University of Wisconsin, Madison

Who can join

18 and older, any sex, with Vitamin A or Vitamin A Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will determine systemic vitamin A status and lesion histopathology of participants with vocal fold hyperkeratosis resulting in clinical leukoplakia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05323292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing